The Procter & Gamble Company (NYSE:PG) Shares Sold by DF Dent & Co. Inc.

DF Dent & Co. Inc. decreased its holdings in The Procter & Gamble Company (NYSE:PG) by 5.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 122,344 shares of the company’s stock after selling 7,397 shares during the period. DF Dent & Co. Inc.’s holdings in Procter & Gamble were worth $21,190,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of PG. Curated Wealth Partners LLC grew its stake in shares of Procter & Gamble by 200.0% in the second quarter. Curated Wealth Partners LLC now owns 1,260 shares of the company’s stock valued at $208,000 after buying an additional 2,520 shares in the last quarter. Evanson Asset Management LLC boosted its holdings in Procter & Gamble by 61.7% in the 2nd quarter. Evanson Asset Management LLC now owns 9,470 shares of the company’s stock worth $1,562,000 after acquiring an additional 3,612 shares during the period. Austin Private Wealth LLC raised its stake in shares of Procter & Gamble by 7.4% during the second quarter. Austin Private Wealth LLC now owns 6,374 shares of the company’s stock valued at $1,051,000 after purchasing an additional 440 shares during the period. MJP Associates Inc. ADV lifted its position in shares of Procter & Gamble by 6.0% during the second quarter. MJP Associates Inc. ADV now owns 7,606 shares of the company’s stock worth $1,254,000 after purchasing an additional 433 shares in the last quarter. Finally, Mechanics Bank Trust Department boosted its stake in shares of Procter & Gamble by 0.5% in the second quarter. Mechanics Bank Trust Department now owns 55,314 shares of the company’s stock valued at $9,122,000 after purchasing an additional 298 shares during the period. 65.77% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently issued reports on PG. Wells Fargo & Company lifted their price target on shares of Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research note on Friday, November 22nd. Piper Sandler started coverage on Procter & Gamble in a report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price target for the company. Royal Bank of Canada restated a “sector perform” rating and set a $164.00 price objective on shares of Procter & Gamble in a report on Monday, October 21st. DA Davidson raised shares of Procter & Gamble from a “neutral” rating to a “buy” rating and raised their price target for the stock from $160.00 to $209.00 in a research report on Monday, November 25th. Finally, Morgan Stanley upped their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Eight research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $180.45.

Procter & Gamble Price Performance

Shares of PG opened at $173.83 on Friday. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The company has a market cap of $409.38 billion, a P/E ratio of 29.97, a PEG ratio of 3.77 and a beta of 0.44. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $180.43. The stock has a fifty day moving average price of $170.75 and a 200 day moving average price of $169.34.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business had revenue of $21.74 billion during the quarter, compared to the consensus estimate of $21.99 billion. During the same period in the previous year, the firm posted $1.83 earnings per share. The business’s revenue was down .6% on a year-over-year basis. On average, research analysts forecast that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $1.0065 per share. The ex-dividend date was Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.32%. Procter & Gamble’s dividend payout ratio is presently 69.48%.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction dated Thursday, November 21st. The shares were sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the transaction, the insider now directly owns 11,595 shares in the company, valued at $2,002,804.35. This trade represents a 52.47 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 83,080 shares of company stock valued at $14,629,038. Corporate insiders own 0.18% of the company’s stock.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.